A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI) "ATLANTIC"

Completed

Phase 4 Results

Summary of Purpose

The aim of this study is to determine whether initiation of ticagrelor as early as in the ambulance setting leads to a rapid reperfusion of the infarct-related artery therefore facilitating the Percutaneous Coronary Intervention (PCI) and optimizing the outcome for the patient. The study will assess the efficacy and safety of pre-hospital compared to in-hospital administration of ticagrelor in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 July 2015.

1 Sep 2011 19 Apr 2011 1 Nov 2013 1 Nov 2013 1 Jul 2015 13 Nov 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

  • AstraZeneca Clinical Study Information

    800-236-9933